NCT05361668 2025-10-31Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeCrinetics Pharmaceuticals Inc.Phase 2 Active not recruiting36 enrolled 19 charts